<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guo CR</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>10827</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12673082</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Despite intensive development, P2X7 modulators have struggled in translation due to human genetic variability and species-dependent drug responses. Here, we identify PSFL1191, a portal-of-central-pocket (PCP)-site inhibitor selective for human and panda P2X7, but inactive against rodents. Cryo-EM structures revealed two distinct PCP sub-pockets: PCP1, a rigid base pocket demanding precise steric complementarity with PSFL1191, and PCP2, a conserved middle cavity targeted by JNJ-54175446, a clinical candidate unaffected by species differences. Species selectivity maps to a deep PCP1 motif (V312-Y295-M105-F103-P96). In P2rx7&lt;sup>A312V/A312V&lt;/sup> mice, PSFL1191 markedly altered macrophage-mediated bacterial clearance and wound healing while preserving basal physiology, effects absent in wild-</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Understanding interspecies drug response variations between human and rodent P2X7 receptors.</pubmed_title><pmcid>PMC12673082</pmcid><funding_grant_id>32371289</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Guo CR</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Wang DP</pubmed_authors><pubmed_authors>Shen C</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Sheng D</pubmed_authors><pubmed_authors>Li JY</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Jin F</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Zhao YY</pubmed_authors><pubmed_authors>Yao JB</pubmed_authors><pubmed_authors>Li TT</pubmed_authors><pubmed_authors>Cao P</pubmed_authors><pubmed_authors>Hattori M</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Understanding interspecies drug response variations between human and rodent P2X7 receptors.</name><description>Despite intensive development, P2X7 modulators have struggled in translation due to human genetic variability and species-dependent drug responses. Here, we identify PSFL1191, a portal-of-central-pocket (PCP)-site inhibitor selective for human and panda P2X7, but inactive against rodents. Cryo-EM structures revealed two distinct PCP sub-pockets: PCP1, a rigid base pocket demanding precise steric complementarity with PSFL1191, and PCP2, a conserved middle cavity targeted by JNJ-54175446, a clinical candidate unaffected by species differences. Species selectivity maps to a deep PCP1 motif (V312-Y295-M105-F103-P96). In P2rx7&lt;sup>A312V/A312V&lt;/sup> mice, PSFL1191 markedly altered macrophage-mediated bacterial clearance and wound healing while preserving basal physiology, effects absent in wild-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-11T04:44:58.143Z</modification><creation>2026-06-11T03:07:52.431Z</creation></dates><accession>S-EPMC12673082</accession><cross_references><pubmed>41330895</pubmed><doi>10.1038/s41467-025-65847-0</doi></cross_references></HashMap>